Immune system being the defence centre of our body provides immunity which is termed as the process in which our body defends itself against a foreign particle. Immunology is a large therapy area characterized by maladies of the immune system, specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or acute inflammation.
Immunology is an integral of other branches and each branch is inter dependent. Depending on the specific site affected, this can lead to various types of chronic pain and loss of mobility, and have a negative impact on quality of life.
This disease area has a total of 2,145 yields in active development, trailing only oncology, infectious diseases and central nervous system disorders in terms of channel size. There are a total of 529 immunology pipeline products that act on first-in-class molecular targets, representing approximately 40% of the total immunology pipeline for which the molecular target was disclosed.
Due to a degree of crossover between immunology indications in terms of their underlying pathophysiology, it is not uncommon for products being developed for this therapy area to have developmental programs testing them across multiple indications.